Trials / Completed
CompletedNCT00190970
The Effect of Ruboxistaurin on Small Fiber Function
The Effect of Ruboxistaurin Mesylate (LY333531) on Small Fiber Function as Measured by Microvascular Skin Blood Flow, C-Fiber Quantitations in Skin and Quantitative Sensory Testing of Cold and Heat.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 52 (planned)
- Sponsor
- Chromaderm, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the effect of Ruboxistaurin on small fiber function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ruboxistaurin |
Timeline
- Start date
- 2004-10-01
- Completion
- 2005-11-01
- First posted
- 2005-09-19
- Last updated
- 2016-07-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00190970. Inclusion in this directory is not an endorsement.